Concepedia

C Shih

CS

Statistics

Publications

16

Citations

2.1K

H-Index

14

Active since

1983

Affiliations

Eli Lilly (United States)(Current)

Harvard University

Princeton University

Brigham and Women's Hospital

C Shih is an author at Eli Lilly (United States) specializing in pharmacology, medicine, and cancer pharmacology.

Publications per year

1983–2024

16

Publications

16

LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes.

C Shih, V J Chen, Lynn S. Gossett et al. · PubMed · 1997 · 565 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis.

E. J. Corey, C Shih, John R. Cashman · Proceedings of the National Academy of Sciences · 1983 · 417 citations · Full text

Life Sciences, Biochemistry, Nutritional Sciences +13

Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product.

T H Lee, J M Menica-Huerta, C Shih et al. · Journal of Biological Chemistry · 1984 · 304 citations · Full text

Life Sciences, Biochemistry, Pharmacology +13

Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.

T H Lee, Jean‐Michel Mencia‐Huerta, C Shih et al. · Journal of Clinical Investigation · 1984 · 269 citations · Full text

Life Sciences, Biochemistry, Pharmacology +14

Role of thymidylate synthase in the antitumor activity of the multitargeted antifolate, LY231514.

Richard M. Schultz, Vinod F. Patel, John F. Worzalla et al. · PubMed · 1999 · 111 citations

Medicine, Oncology, Pharmacology +11

1–5 of 16